Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: E9ASR5
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 1 |
GO:0005509 | calcium ion binding | 5 | 1 |
GO:0043167 | ion binding | 2 | 1 |
GO:0043169 | cation binding | 3 | 1 |
GO:0046872 | metal ion binding | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 104 | 108 | PF00656 | 0.423 |
CLV_NRD_NRD_1 | 56 | 58 | PF00675 | 0.538 |
CLV_PCSK_SKI1_1 | 140 | 144 | PF00082 | 0.356 |
CLV_PCSK_SKI1_1 | 49 | 53 | PF00082 | 0.411 |
CLV_PCSK_SKI1_1 | 86 | 90 | PF00082 | 0.379 |
DEG_SPOP_SBC_1 | 101 | 105 | PF00917 | 0.512 |
DOC_USP7_MATH_1 | 101 | 105 | PF00917 | 0.573 |
DOC_USP7_MATH_1 | 3 | 7 | PF00917 | 0.713 |
LIG_14-3-3_CanoR_1 | 133 | 137 | PF00244 | 0.504 |
LIG_14-3-3_CanoR_1 | 86 | 91 | PF00244 | 0.392 |
LIG_14-3-3_CanoR_1 | 94 | 100 | PF00244 | 0.429 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.656 |
LIG_BIR_III_4 | 129 | 133 | PF00653 | 0.496 |
LIG_BRCT_BRCA1_1 | 64 | 68 | PF00533 | 0.610 |
LIG_FHA_1 | 8 | 14 | PF00498 | 0.481 |
LIG_FHA_2 | 67 | 73 | PF00498 | 0.433 |
LIG_LIR_Gen_1 | 74 | 84 | PF02991 | 0.406 |
LIG_LIR_Nem_3 | 137 | 142 | PF02991 | 0.357 |
LIG_LIR_Nem_3 | 31 | 36 | PF02991 | 0.422 |
LIG_LIR_Nem_3 | 74 | 80 | PF02991 | 0.382 |
LIG_NRBOX | 142 | 148 | PF00104 | 0.518 |
LIG_PCNA_yPIPBox_3 | 22 | 33 | PF02747 | 0.336 |
LIG_SH2_STAT5 | 23 | 26 | PF00017 | 0.426 |
LIG_SH3_1 | 42 | 48 | PF00018 | 0.383 |
LIG_SH3_3 | 10 | 16 | PF00018 | 0.651 |
LIG_SH3_3 | 42 | 48 | PF00018 | 0.403 |
LIG_SUMO_SIM_par_1 | 78 | 83 | PF11976 | 0.343 |
LIG_TRAF2_1 | 118 | 121 | PF00917 | 0.490 |
LIG_WRC_WIRS_1 | 136 | 141 | PF05994 | 0.252 |
MOD_CK1_1 | 135 | 141 | PF00069 | 0.277 |
MOD_CK1_1 | 6 | 12 | PF00069 | 0.668 |
MOD_CK1_1 | 66 | 72 | PF00069 | 0.553 |
MOD_CK2_1 | 135 | 141 | PF00069 | 0.254 |
MOD_CK2_1 | 72 | 78 | PF00069 | 0.503 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.718 |
MOD_GlcNHglycan | 104 | 107 | PF01048 | 0.550 |
MOD_GlcNHglycan | 111 | 114 | PF01048 | 0.640 |
MOD_GSK3_1 | 142 | 149 | PF00069 | 0.550 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.502 |
MOD_GSK3_1 | 62 | 69 | PF00069 | 0.397 |
MOD_N-GLC_1 | 107 | 112 | PF02516 | 0.496 |
MOD_N-GLC_2 | 95 | 97 | PF02516 | 0.363 |
MOD_NEK2_1 | 100 | 105 | PF00069 | 0.484 |
MOD_NEK2_1 | 146 | 151 | PF00069 | 0.571 |
MOD_NEK2_1 | 93 | 98 | PF00069 | 0.378 |
MOD_PKA_2 | 132 | 138 | PF00069 | 0.505 |
MOD_PKA_2 | 93 | 99 | PF00069 | 0.421 |
MOD_Plk_2-3 | 72 | 78 | PF00069 | 0.375 |
MOD_Plk_4 | 142 | 148 | PF00069 | 0.477 |
MOD_Plk_4 | 63 | 69 | PF00069 | 0.517 |
MOD_Plk_4 | 72 | 78 | PF00069 | 0.384 |
MOD_SUMO_rev_2 | 55 | 65 | PF00179 | 0.519 |
TRG_ER_diLys_1 | 150 | 154 | PF00400 | 0.508 |
TRG_Pf-PMV_PEXEL_1 | 57 | 61 | PF00026 | 0.492 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HX85 | Leptomonas seymouri | 65% | 92% |
A0A0S4JG18 | Bodo saltans | 54% | 100% |
A0A1X0P8S8 | Trypanosomatidae | 53% | 97% |
A0A3Q8IKE9 | Leishmania donovani | 88% | 99% |
A0A422NI72 | Trypanosoma rangeli | 54% | 100% |
A4HP05 | Leishmania braziliensis | 82% | 100% |
A4IDB4 | Leishmania infantum | 89% | 99% |
D0A2Y1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 100% |
Q4Q1T1 | Leishmania major | 91% | 100% |
V5BJX8 | Trypanosoma cruzi | 52% | 100% |